Cortexyme shares tumbled more than 70% in premarket trading

Tiger Newspress2021-10-27

Cortexyme shares tumbled more than 70% in premarket trading.Cortexyme Inc said on Tuesday its experimental oral pill failed to meet the main goals of improving cognitive and functional abilities in patients with mild-to-moderate Alzheimer's disease in a study.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • FrederickL
    2021-10-28
    FrederickL
    Opps
  • Chris68
    2021-10-28
    Chris68
    Good
  • CCCH
    2021-10-27
    CCCH
    Good luck 
  • SanWangtikup
    2021-10-27
    SanWangtikup
    [Smug] 
  • Juanlee
    2021-10-27
    Juanlee
    Biopharmacology is difficult business.  Long duration of research, testing and capital  and high chance of fail.
  • CIG
    2021-10-27
    CIG
    以为是宝 惊觉是草 
    • tkj
      it depends. it will be treasure if its pills meet the target but now it is trash.....there goes the lottery ticket
发表看法
8